Laurence F. Prescott

Laurence F. Prescott's AcademicInfluence.com Rankings

Medical

#1353

World Rank

#1680

Historical Rank

Toxicology

World Rank

#10

Historical Rank

Pharmacology

#104

World Rank

#133

Historical Rank

medical Degrees

Laurence F. Prescott

Philosophy

#4348

World Rank

#6829

Historical Rank

Logic

#1828

World Rank

#2673

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Laurence F. Prescott's Degrees

PhD Pharmacology University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is Laurence F. Prescott Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Laurence F. Prescott's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. (1971) (587)
The dependence of paracetamol absorption on the rate of gastric emptying (1973) (579)
Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning. (1979) (578)
Clinical Pharmacokinetics of Paracetamol (1982) (414)
Kinetics and metabolism of paracetamol and phenacetin. (1980) (409)
TREATMENT OF PARACETAMOL (ACETAMINOPHEN) POISONING WITH N-ACETYLCYSTEINE (1977) (399)
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. (1979) (244)
Pharmacological Modification of Gastric Emptying: Effects of Propantheline and Metoclopromide on Paracetamol Absorption (1973) (243)
Paracetamol metabolism following overdosage: application of high performance liquid chromatography (1977) (229)
Paracetamol, alcohol and the liver. (2000) (212)
Successful treatment of severe paracetamol overdosage with cysteamine. (1974) (206)
Paracetamol: Past, Present, and Future (2000) (195)
CYSTEAMINE, METHIONINE, AND PENICILLAMINE IN THE TREATMENT OF PARACETAMOL POISONING (1976) (183)
Paracetamol overdosage. Pharmacological considerations and clinical management. (1983) (157)
Rapid gas‐liquid chromatographic estimation of antipyrine in plasma (1973) (151)
Isolation and Identification of Drugs. (1970) (146)
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). (1973) (144)
Inter-subject and ethnic differences in paracetamol metabolism. (1986) (140)
The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage (2004) (138)
Liver damage and impaired glucose tolerance after paracetamol overdosage. (1966) (128)
Paracetamol Overdosage (1983) (120)
Absorption, distribution and elimination of mexiletine. (1977) (119)
Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure. (1976) (114)
The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage.: A pharmacokinetic study (1973) (113)
EFFECTS OF ACETYLSALICYLIC ACID, PHENACETIN, PARACETAMOL, AND CAFFEINE ON RENAL TUBULAR EPITHELIUM. (1965) (103)
Pharmacokinetic drug interactions. (1969) (102)
Oral or intravenous N-acetylcysteine for acetaminophen poisoning? (2005) (102)
The treatment of acetaminophen poisoning. (1983) (97)
Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. (1981) (94)
Diuresis or urinary alkalinisation for salicylate poisoning? (1982) (93)
Therapeutic Misadventure with Paracetamol: Fact or Fiction? (2000) (92)
Effects of microsomal enzyme induction on paracetamol metabolism in man. (1981) (85)
Gastric emptying and drug absorption. (1974) (84)
Gas‐liquid chromatographic estimation of paracetamol (1971) (84)
The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. (1984) (81)
Experimental paracetamol‐induced hepatic necrosis: A histopathological study (1971) (80)
Death and blindness due to overdose of quinine. (1985) (79)
Gastrointestinal absorption of drugs. (1974) (78)
Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. (1977) (76)
The gas‐liquid chromatographic estimation of phenacetin and paracetamol in plasma and urine (1971) (76)
High performance liquid chromatographic estimation of paracetamol metabolites in plasma. (1978) (74)
Treatment of drug overdosage with naloxone, a specific narcotic antagonist. (1973) (72)
Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. (1985) (71)
A SIMPLE DIFFERENTIAL STAIN FOR URINARY SEDIMENT. (1964) (70)
Hepatotoxicity of mild analgesics. (1980) (67)
Plasma glutathione S-transferase and F protein are more sensitive than alanine aminotransferase as markers of paracetamol (acetaminophen)-induced liver damage. (1989) (67)
MEFENAMIC ACID NEPHROPATHY (1980) (65)
Treatment of severe 2,4-D and mecoprop intoxication with alkaline diuresis. (1979) (65)
Paracetamol metabolites in the neonate following maternal overdose. (1984) (65)
The effects of particle size on the absorption of phenacetin in man (1970) (63)
IS THERE A PLACE FOR CIMETIDINE OR ETHANOL IN THE TREATMENT OF PARACETAMOL POISONING? (1983) (62)
Handbook of clinical pharmacokinetics (1983) (59)
The comparative metabolism of phenacetin and N‐acetyl‐p‐aminophenol in man, with particular reference to effects on the kidney (1968) (55)
Fatal pulmonary aspiration of oral activated charcoal. (1988) (54)
Drug Interactions with Paracetamol (2005) (52)
Paracetamol metabolism in chronic liver disease (1979) (49)
Analgesic abuse and renal disease in North-East Scotland. (1966) (49)
The metabolism of phenacetin in patients with renal disease (1969) (49)
Mexiletine in the Prophylaxis of Ventricular Arrhythmias During Acute Myocardial Infarction (1979) (48)
The effects of repeated administration of mercuric chloride on exfoliation of renal tubular cells and urinary glutamic-oxaloacetic transaminase activity in the rat. (1969) (48)
Diuresis or urinary alkalinisation for salicylate poisoning? (1983) (48)
Drill's Pharmacology in Medicine. (1967) (47)
Drugs prescribed for self poisoners. (1985) (46)
MEFENAMIC ACID OVERDOSAGE (1981) (46)
Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments. (1998) (45)
Treatment of salicylate poisoning with repeated oral charcoal. (1985) (45)
Gas‐liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma (1972) (45)
Self-poisoning and Therapeutic Intoxication with Lithium (1987) (45)
Why do patients still die from paracetamol poisoning? (1986) (45)
Unusual complications of paracetamol poisoning. (1997) (44)
Abnormal Drug Metabolism after Barbiturate and Paracetamol Overdose (1974) (44)
Spectrophotofluorometric and gas‐liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine (1973) (43)
Cardiac complications of carbamazepine intoxication: treatment by haemoperfusion. (1983) (42)
REDUCED FELODIPINE BIOAVAILABILITY IN PATIENTS TAKING ANTICONVULSANTS (1988) (41)
The nephrotoxicity of analgesics (1966) (41)
Combined Clinical and Metabolic Study of the Effects of Alpha‐Methyldopa on Hypertensive Patients (1966) (41)
Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. (1986) (40)
Assessment of nephrotoxicity. (1982) (40)
Drug metabolism in liver disease (1975) (39)
Paracetamol disposition and metabolite kinetics in patients with chronic renal failure (2004) (39)
Haemodialysis for Paraquat Poisoning (1987) (38)
Drug interactions affecting analgesic toxicity. (1983) (37)
Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man (1976) (37)
Inappropriate Methods for the Emergency Determination of Plasma Paracetamol (1979) (37)
Reassessment of the single intravenous injection method with inulin for measurement of the glomerular filtration rate in man. (1991) (36)
Acetaminophen absorption and metabolism in celiac disease and Crohn's disease (1981) (35)
The third Lilly Prize Lecture. University of London, January, 1979. The nephrotoxicity and hepatotoxicity of antipyretic analgesics. (1979) (35)
Gas‐liquid chromatographic estimation of lignocaine, ethylglycylxylidide, glycylxylidide and 4‐hydroxyxylidine in plasma and urine (1974) (34)
Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. (1973) (33)
Treatment of quinine overdosage with repeated oral charcoal. (1989) (32)
Glutathione: a protective mechanism against hepatotoxicity. (1982) (31)
Dose-dependent absorption and elimination of cefadroxil in man (2004) (30)
CYSTEAMINE FOR PARACETAMOL OVERDOSAGE (1974) (29)
Mechanisms of renal excretion of drugs (with special reference to drugs used by anaesthetists). (1972) (29)
The absorption of aspirin and paracetamol in patients with achlorhydria (1974) (27)
Pharmacokinetics of N‐acetylcysteine are altered in patients with chronic liver disease (1997) (27)
Gross impairment of hepatic drug metabolism in a patient with chronic liver disease. (1974) (26)
Mefenamic acid poisoning and epilepsy. (1979) (25)
Mexiletine disposition: individual variation in response to urine acidification and alkalinisation. (1983) (25)
The Toxic Effects of Alpha-Chloralose (1988) (25)
Acute haemolysis and renal failure after nomifensine overdosage. (1980) (25)
ACTIVATED CHARCOAL FOR CARBAMAZEPINE POISONING (1987) (24)
Impaired absorption and metabolism of oral lignocaine in patients undergoing laparoscopy. (1973) (23)
The comparative effects of paracetamol and indomethacin on renal function in healthy female volunteers. (1990) (23)
Paracetamol-induced acute renal failure in the absence of fulminant liver damage. (1982) (23)
Controversies in management: Should methionine be added to every paracetamol tablet? (1997) (22)
Clinically Important Drug Interactions (2012) (21)
Hyponatraemia at a rave. (1997) (21)
The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function. (1993) (21)
The concentration-dependent disposition and kinetics of inulin (1991) (21)
Analgesic Nephropathy: A Reassessment of the Role of Phenacetin and Other Analgesics (2012) (20)
Side effects of benoxaprofen (1982) (20)
Cysteamine, L-Methionine and D-Penicillamine in Paracetamol Poisoning (1976) (19)
Intravenous N-Acetylcysteine, Hepatotoxicity and Plasma Glutathione S-Transferase in Patients with Paracetamol Overdosage (1990) (18)
Accidental hypothermia. A common condition. (1962) (18)
Generic inequivalence--clinical observations. (2009) (18)
Impaired absorption of paracetamol in vegetarians. (1993) (17)
Pathological and Physiological Factors Affecting Drug Absorption, Distribution, Elimination, and Response in Man (1975) (17)
Rapid gas--liquid chromatographic estimation of doxapram in plasma. (1977) (17)
Analgesic nephropathy--the international experience. (1976) (16)
The Pharmacological Basis of Therapeutics (ed 3). (1966) (15)
Fulminant Hyperkalaemia and Multiple Complications Following Ibuprofen Overdose (1989) (15)
New approaches in managing drug overdosage and poisoning. (1983) (15)
Failure of Induction of Liver Microsomal Enzymes by Tolbutamide in Maturity-Onset Diabetics (1973) (15)
Effects of Non-Narcotic Analgesics on the Liver (2012) (14)
Lignocaine metabolism in man. (1973) (13)
The chief scientist reports ... prevention of hepatic necrosis following paracetamol overdosage. (1978) (13)
The hepatotoxicity of non-steroidal anti-inflammatory drugs (1992) (13)
Phenylbutazone overdosage: abnormal metabolism associated with hepatic and renal damage. (1980) (13)
Failure of alkaline diuresis to enhance diflunisal elimination. (1980) (13)
Why Medical Toxicology? (1986) (12)
Future Perspectives with Paracetamol (2003) (12)
Haemodialysis in paracetamol self-poisoning. (1972) (12)
Proceedings: Antipyrine, lingocaine and paracetamol metabolism in chronic liver disease. (1975) (11)
TREATMENT OF DRUG OVERDOSAGE WITH NALOXONE, A SPECIFIC NARCOTIC ANTAGONIST (1974) (11)
Cysteamine or N-acetylcysteine for paracetamol poisoning? (1978) (11)
The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure (2004) (11)
The effect of chloroquine on paracetamol disposition and kinetics. (1986) (11)
Paracetamol elimination in Chinese and Indians in Singapore (2005) (11)
AVOIDANCE OF MEFENAMIC ACID IN EPILEPSY (1981) (10)
Liver damage with non-narcotic analgesics. (1986) (10)
CYSTEAMINE FOR PARACETAMOL POISONING (1976) (10)
Clinical pharmacological studies of Kö 1173--a new antiarrhythmic agent. (1973) (10)
FACTORS PREDISPOSING TO ADVERSE DRUG REACTIONS (1979) (10)
Drug conjugation in clinical toxicology. (1984) (10)
Repeated self-poisoning with paracetamol. (1978) (9)
The effects of particle size on the absorption of phenacetin in man. A correlation between plasma concentration of phenacetin and effects on the central nervous system. (1970) (9)
[New perspectives on paracetamol]. (2003) (9)
Metabolic and hypotensive effects of ethacrynic acid. Comparative study with hydrochlorothiazide. (1968) (9)
Clinical Features and Management of Analgesic Poisoning (1984) (9)
Fatal pulmonary aspiration of oral activated charcoal. (1988) (9)
Effects of mepyramine, promethazine, and hydrocortisone on paracetamol-induced hepatic necrosis in the rat. (1973) (9)
Paracetamol poisoning. Prevention of liver damage. (1979) (8)
URINARY WHITE-CELL EXCRETION PATTERNS (1965) (8)
SI, moles, and drugs. (1978) (8)
Panel discussion. Management of acetaminophen overdose. (1981) (7)
The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis (2004) (7)
The disposition of intravenous doxapram in man (2004) (7)
Paracetamol pharmacokinetics in thyroid disease (1980) (7)
The Medicated Society. (1969) (6)
Rapid estimation of diflunisal in plasma and urine by high-performance liquid chromatography and a comparison with a fluorometric method. (1982) (6)
Anti-inflammatory analgesics and drugs used in rheumatism and gout (1978) (6)
WHO NEEDS MOLAR UNITS FOR DRUGS? (1987) (6)
Furosemide disposition in patients on CAPD (2004) (6)
Radiotherapy for paraquat lung toxicity (1984) (6)
The effect of atropine on the oral absorption of lidocaine in man (1974) (5)
B.A.L. IN PARACETAMOL POISONING (1974) (5)
Absorption and Clearance of Ceftazidime during CAPD (1995) (5)
ETHANOL IN PARACETAMOL POISONING (1983) (5)
Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure. (1991) (5)
The development of intravenous mexiletine dose regimes. (1977) (4)
The interaction of paracetamol with frusemide. (1994) (4)
HEPATOTOXIC DOSE OF PARACETAMOL (1977) (4)
High-performance liquid chromatography in clinical and biological chemistry (1979) (4)
Methyldopa and Parkinsonism (1964) (4)
The clinical significance and importance of drug interactions. (1977) (4)
Renal papillary necrosis and aspirin. (1969) (4)
Current status of nephrotoxicity caused by non-steroidal anti-inflammatory drugs (1992) (4)
Pharmacological Modification ofGastric Emptying: Effects ofPropantheline andMetoclopromide on Paracetamol Absorption (1973) (4)
Ko 1173--an effective new antiarrhythmic drug. (1973) (4)
Limitations of Haemodialysis and Forced Diuresis (2008) (3)
Neonatal Thrombocytopenia and Thiazide Drugs (1964) (3)
Clinical drug toxicology. (1992) (3)
Lignocaine in donor blood. (1973) (3)
Brown urine--a clue to phenacetin intoxication. (1970) (3)
Henry Matthew: the father of modern clinical toxicology. (2009) (3)
Letter: Treatment of paracetamol poisoning. (1975) (3)
Paracetamol disposition in renal allograft recipients (2002) (3)
Current Status of Issues Concerning the Safety of Over-the-Counter Analgesics and Nonsteroidal Anti-Inflammatory Drugs (1998) (3)
Distalgesic abuse and retroperitoneal fibrosis. (1985) (3)
Abnormal Drug Metabolism following Barbiturate and Paracetamol Overdosage (1974) (3)
Inadequate information about drug overdosage in manufacturers' data sheets. (1980) (3)
Drug interaction during absorption (2004) (2)
Naratriptan provides effective migraine control (1997) (2)
Asthma associated with N-acetylcysteine infusion and paracetamol poisoning (1984) (2)
A physiologically-based pharmacokinetic model for absorption of oral paracetamol in man [proceedings]. (1978) (2)
Reactive metabolites as a cause of hepatotoxicity. (1983) (2)
Aspirin and renal papillary necrosis. (1971) (2)
Accidental Hypothermia (1962) (2)
Drug Metabolism and Therapeutics (1971) (2)
Frusemide and urinary cell loss. (1968) (2)
Haemodialysis in paracetomol self-poisoning. (1972) (1)
Animal and Clinical Pharmacologic Techniques in Drug Evaluation, vol 2. (1965) (1)
Toxicological Studies in a Distalgesic Addict (1986) (1)
Tiagabine offers effective seizure control (1997) (1)
Comparison of assays for measuring plasma paracetamol (1998) (1)
The hepatotoxicity of paracetamol--clinical aspects. (1982) (1)
Parecoxib: new COX-2 inhibitor suggested for perioperative analgesia (2001) (1)
PHARMACOKINETICS AND DISPOSITION (2002) (1)
DOSE RESPONSE RELATIONSHIPS IN TOXICOLOGY (2000) (1)
Use of molar units for drugs and toxins. (1986) (1)
No: The risks are not well enough known (1997) (1)
Renal effects of acetylsalicylic acid, phenacetin, acetaminophen, and caffeine. (1966) (1)
Rosuvastatin provides superior benefits in lipid therapy (2001) (1)
Misleading Drug Advertising (1975) (1)
IPCS/CEC EVALUATION OF ANTIDOTES SERIES VOLUME 3 ANTIDOTES FOR POISONING BY PARACETAMOL (2003) (1)
Salcatonin nasal spray valuable in postmenopausal osteoporosis (1997) (0)
ANALGESIC ABUSE AND RENAL DISEASE (1967) (0)
Annual Review of Pharmacology, vol 6. (1967) (0)
Accidental paracetamol overdosing and fulminant hepatic failure in children (2000) (0)
High-dose chemotherapy proves useful in breast cancer (1997) (0)
Esomeprazole superior for treating GORD (2001) (0)
Enoxaparin sodium has benefits as post-thrombolytic therapy in acute MI (1997) (0)
Rivastigmine on its best behaviour in Alzheimer's disease (2000) (0)
Quantitative Toxicology: Clinical and Forensie Aspects (1983) (0)
Novel anti-IgE monoclonal antibody promising against allergic diseases (2000) (0)
Phenylbutazone pericarditis. (1982) (0)
Infliximab maintenance therapy valuable strategy in Crohn's disease (2001) (0)
Drug metabolism in liver disease (1975) (0)
Newer products coming along in epilepsy (1998) (0)
Paracetamol metabolism and excretion in paracetamol overdosage complicated by hepatic necrosis (T). (1971) (0)
Electrocardiographic interpretation—Interpretations from three different schools: Enrique Cabrera, E. Harvey Eskes and Herman K. Hellerstein. (Edited by J. Willis Hurst and Nanette Kass Wenger.) The Blakiston Division/McGraw-Hill Book Company, Inc. 308 pp. Indexed. Price $12.95 (1964) (0)
Letter: Cysteamine for paracetamol poisoning. (1976) (0)
Abciximab enhances thrombolytic therapy in acute MI (1997) (0)
Clearer picture of role for tamoxifen in breast cancer (1996) (0)
E2F Decoy therapy prevents graft failures following CABG (2002) (0)
Ranolazine promising in combination therapy for severe angina (2002) (0)
More effective radioimmunotherapy on the way for NHL? (1998) (0)
Massive benefits for patients at risk of CHD in largest lipid-lowering trial (2001) (0)
Letter: B.A.L. in paracetamol poisoning. (1968) (0)
Nicorandil reduces risk of major coronary events in patients with angina (2001) (0)
Fondaparinux sodium promising in preventing major CV events in ACS (2001) (0)
The effect of cephaloridine on renal tubular cell excretion. (1967) (0)
Letters to the EditorANALGESIC NEPHROPATHY (1965) (0)
Drugs and the liver Drug metabolism in liver disease (0)
Diseases of Western civilization. (1973) (0)
New cefalosporin shows promise against respiratory infections (1999) (0)
New therapeutic approaches for treating lymphomas (1996) (0)
Human tumours secreting catecholamines. Clinical and physiopathological study of the pheochromocytoma and . Pergamon Press, Oxford, 1964. 207 pp. Indexed. Price $8.50. (Distributed in America by the Macmillan Co., New York) (1966) (0)
Enoxaparin sodium recommended as antithrombotic of choice in acute MI (2002) (0)
Alendronic acid: benefits in prevention and treatment of PMO (1997) (0)
Methylprednisolone still the best option for acute spinal cord injury (1997) (0)
How will leukotriene inhibitors affect asthma management? (1996) (0)
Can cystitis management be just a phone call away (2003) (0)
Budesonide MRC offers new treatment option for Crohn's disease (2001) (0)
Low risk of drug interactions with venlafaxine (1997) (0)
Multiorgan failure in the critically ill (2013) (0)
Adjunct histamine with immunotherapy promising in AML (1998) (0)
Raltitrexed: cost-effective therapy for colorectal cancer (1997) (0)
Protease inhibitor combinations: a breakthrough in treating HIV infection (1996) (0)
Update on alteplase therapy for acute stroke (1997) (0)
Pleconaril offers potential antiviral treatment for the common cold (2002) (0)
Colesevelam valuable adjunct in lipid-lowering therapy (2001) (0)
Clopidogrel offers first long-term antithrombotic treatment for ACS (2001) (0)
Drug promotion. (1977) (0)
Entacapone boosts levodopa action in Parkinson’s disease (1998) (0)
Drugs of Choice, 1964-5. (1964) (0)
Once-daily valaciclovir suppresses recurrent genital herpes (1997) (0)
Pramipexole: treatment of choice in early Parkinson's disease? (2000) (0)
Medical Pharmacology Principles and Concepts, ed 4. (1969) (0)
New growth factors spurt into action (1998) (0)
An Outline of Therapeutics. (1970) (0)
Drugs for personal fulfillment in the elderly. (2001) (0)
Men with low PSA may not need annual screening (2002) (0)
Animal Behaviour and Drug Action. (1965) (0)
Tezosentan shows potential for treating heart failure (2001) (0)
Letter: Treatment of paracetamol overdosage. (1974) (0)
Telithromycin: a valuable option against community-acquired RTIs (2002) (0)
TREATMENT OF PARACETAMOL OVERDOSAGE (1974) (0)
[Nephropathies due to analgesics. Analgesic nephropathy in Great Britain: a continuing problem]. (1974) (0)
Drugs for personal fulfilment in the elderly (2001) (0)
Treat douche-related bacterial vaginosis to avoid complications (1997) (0)
Dorzolamide valuable in medical treatment of glaucoma (1997) (0)
HOT action promises multiple benefits in hypertension (1997) (0)
Annual Review of Pharmacology, vol 7. (1968) (0)
Americans retreat on SI units. (1992) (0)
Fondaparin sodium offers new standard in VTE prophylaxis (2001) (0)
Long-awaited clinical data for platelet factors (1996) (0)
Points from Letters: Chronic Salicylate Poisoning and Renal Tubular Damage (1965) (0)
Nelfinavir keeps therapy options open (1999) (0)
Multiorgan failure in the critically ill: outcomes and costs (1997) (0)
Iatrogenic complications of drug overdosage and poisoning. (1977) (0)
Phenacetin nephropathy. (1970) (0)
QJM Unusual complications of paracetamol poisoning (1997) (0)
Drug promotion. (1977) (0)
New hormonal approaches for osteoporosis on the horizon (1997) (0)
Esomeprazole promises better control of GORD (2000) (0)
Zolmitriptan zaps migraine in ‘real-life’ setting (1998) (0)
Alendronic acid improves outcomes in postmenopausal osteoporosis (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Laurence F. Prescott?

Laurence F. Prescott is affiliated with the following schools:

Laurence F. Prescott's Academic­Influence.com Rankings

Laurence F. Prescott's Degrees

Why Is Laurence F. Prescott Influential?

Laurence F. Prescott's Published Works

Published Works

What Schools Are Affiliated With Laurence F. Prescott?

Laurence F. Prescott's AcademicInfluence.com Rankings